Literature DB >> 25491667

Future of sustained protein delivery.

Ravi Vaishya1, Ashim K Mitra.   

Abstract

Entities:  

Keywords:  biodegradable polymers; controlled release; implants; protein delivery; protein stability; sustained delivery

Mesh：

Substances：

Year:  2014        PMID： 25491667      PMCID： PMC5523982          DOI： 10.4155/tde.14.86

Source DB:  PubMed          Journal:  Ther Deliv        ISSN： 2041-5990


× No keyword cloud information.
  17 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer.

Authors:  J C Wright; S Tao Leonard; C L Stevenson; J C Beck; G Chen; R M Jao; P A Johnson; J Leonard; R J Skowronski
Journal:  J Control Release       Date:  2001-07-10       Impact factor: 9.776

3.  Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release.

Authors:  Wim Jiskoot; Theodore W Randolph; David B Volkin; C Russell Middaugh; Christian Schöneich; Gerhard Winter; Wolfgang Friess; Daan J A Crommelin; John F Carpenter
Journal:  J Pharm Sci       Date:  2011-12-14       Impact factor: 3.534

Review 4.  Critical variables associated with nonbiodegradable osmotically controlled implants.

Authors:  Jeremy C Wright
Journal:  AAPS J       Date:  2010-05-19       Impact factor: 4.009

5.  Analytical methods for the characterization and quality control of pharmaceutical peptides and proteins, using erythropoietin as an example.

Authors:  D Gilg; B Riedl; A Zier; M F Zimmermann
Journal:  Pharm Acta Helv       Date:  1996-12

6.  Pharmaceutical development of biologics: fundamentals, challenges and recent advances.

Authors:  Jing Su; Jeffrey Mazzeo; Nanda Subbarao; Tuo Jin
Journal:  Ther Deliv       Date:  2011-07

7.  Aggregation and chemical modification of monoclonal antibodies under upstream processing conditions.

Authors:  Stefan Dengl; Marc Wehmer; Friederike Hesse; Florian Lipsmeier; Oliver Popp; Kurt Lang
Journal:  Pharm Res       Date:  2013-01-16       Impact factor: 4.200

Review 8.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

Review 9.  Role of solvation effects in protein denaturation: from thermodynamics to single molecules and back.

Authors:  Jeremy L England; Gilad Haran
Journal:  Annu Rev Phys Chem       Date:  2011       Impact factor: 12.703

10.  Tailor-made pentablock copolymer based formulation for sustained ocular delivery of protein therapeutics.

Authors:  Sulabh P Patel; Ravi Vaishya; Gyan Prakash Mishra; Viral Tamboli; Dhananjay Pal; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2014-06-22
View more
  1 in total

1.  Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.

Authors:  Ravi D Vaishya; Abhirup Mandal; Mitan Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-05-01       Impact factor: 5.875
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.